CVS · 10-Q · 2026Q2 · Full report

Liquidity and Cash Position

CVS HEALTH Corp · 2026-08-05 · Importance 69 · Surprise 64 · Matches filing data

CVS Health held approximately $11.3 billion of cash and cash equivalents as of June 30, 2026, including approximately $2.7 billion at the parent company or unrestricted subsidiaries. Operating cash flow increased 64.2% to $10.6 billion in the first six months of 2026 from $6.5 billion in the prior year. Investing cash outflows increased $972 million to $2.8 billion, primarily because of higher net purchases of investments. Financing cash outflows increased $3.5 billion to $5.0 billion, primarily due to higher long-term debt repayments, producing a $2.8 billion net increase in cash, cash equivalents and restricted cash.

Key facts

• Net cash provided by operating activities for the six months ended June 30, 2026 was $10,594 million, an increase of $4,141 million or 64.2% versus prior year. source
• The Company believes its operating cash flows, commercial paper program, credit facilities, as well as any potential future borrowings, will be sufficient to fund future payments and long-term initiatives. source
• Net cash used in investing activities for the six months ended June 30, 2026 was $(2,758) million, an increase in use of $972 million or 54.4% versus prior year. source
• As of June 30, 2026, the Company had approximately $11.3 billion in cash and cash equivalents, approximately $2.7 billion of which was held by the parent company or nonrestricted subsidiaries. source
• Net increase in cash, cash equivalents and restricted cash for the six months ended June 30, 2026 was $2,825 million. source

Impact estimates